DOCS Stock Analysis: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$20.07
-0.39 (-1.91%)
▼
5d:
+0.15%
30d:
+1.06%
90d:
-17.78%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 4.7/10
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DOCS shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: DOCS shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.79
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$23.46
14.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $20.07, which is considered fair relative to its 30-day fair value range of $19.40 to $21.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.4) compared to its historical average (18.8). Remarkably, the market is currently pricing in an annual earnings decline of 13.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $19.45, while resistance sits at $21.07.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.42 (+26.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $19.45, while resistance sits at $21.07.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.42 (+26.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$19.40 -
$21.16
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.7% below Wall St target ($25.42)
Trading Range Analysis
30-Day Trading Range
$19.40 -
$21.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.45
Resistance Level
$21.07
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.38
Wall Street Target
$25.42
(+26.7%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
-69.0%
Profit Margin
30.4%
Valuation Discount vs History
-13.0% cheaper
PE vs Historical
12.4 vs 18.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.0%
(market-implied from PE analysis)
1-Year Target
$18.06
(-10%)
2-Year Target
$16.26
(-19%)
3-Year Target
$14.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 12→19)
$22.21
(+11%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 4.8%)
$40.62
(+102%)
Base:
(SPY PE: 12.4, Growth: 4.8%)
$23.10
(+15%)
Bear:
(PE: 10.5, Growth: 4.8%)
$19.63
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 20.88 | Current EPS (TTM): $0.98
Bull Case
$37.22
(+86%)
Analyst growth 65.4%, PE expands to 23.0
Base Case
$33.84
(+69%)
Market implied 65.4%, PE stable at 20.9
Bear Case
$13.91
(-31%)
Severe decline -20.0%, PE contracts to 17.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.4 to 18.8
Stabilization Target:
$30.47
(+51.8%)
PE Expansion Potential:
+51.8%
Share & Embed Analysis
Last updated: June 23, 2026 4:39 AM ET
Data refreshes hourly during market hours. Next update: 5:39 AM
Data refreshes hourly during market hours. Next update: 5:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram
SELL
2427 shares
2026-04-10
Siddharth Sitaram
SELL
2319 shares
2026-03-10
Kira Scherer Wampler
SELL
2000 shares
2026-03-03
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 57 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 55 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 55 HOLD |
Advanced DOCS Option Strategies
Professional options setups generated by AI based on today's DOCS price and gamma walls.
